Relationship Between Age at Menopause, Obesity, and Incident Heart Failure: The Atherosclerosis Risk in Communities Study
Author
Ebong, I.A.Wilson, M.D.
Appiah, D.
Michos, E.D.
Racette, S.B.
Villablanca, A.
Breathett, K.
Lutsey, P.L.
Wellons, M.
Watson, K.E.
Chang, P.
Bertoni, A.G.
Affiliation
Department of Medicine Division of Cardiovascular Medicine University of ArizonaIssue Date
2022
Metadata
Show full item recordPublisher
WILEY-BLACKWELLCitation
Ebong, I. A., Wilson, M. D., Appiah, D., Michos, E. D., Racette, S. B., Villablanca, A., Breathett, K., Lutsey, P. L., Wellons, M., Watson, K. E., Chang, P., & Bertoni, A. G. (2022). Relationship Between Age at Menopause, Obesity, and Incident Heart Failure: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association.Rights
© 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background The mechanisms linking menopausal age and heart failure (HF) incidence are controversial. We investigated for heterogeneity by obesity on the relationship between menopausal age and HF incidence. Methods and Results Using postmenopausal women who attended the Atherosclerosis Risk in Communities Study Visit 4, we estimated hazard ratios of incident HF associated with menopausal age using Cox proportional hazards models, testing for effect modification by obesity and adjusting for HF risk factors. Women were categorized by menopausal age: <45 years, 45 to 49 years, 50 to 54 years, and ≥55 years. Among 4441 postmenopausal women, aged 63.5±5.5 years, there were 903 incident HF events over a mean follow-up of 16.5 years. The attributable risk of generalized and central obesity for HF incidence was greatest among women who experienced menopause at age ≥55 years: 11.09/1000 person-years and 7.38/1000 person-years, respectively. There were significant interactions of menopausal age with body mass index and waist circumference for HF incidence, Pinteraction 0.02 and 0.001, respectively. The hazard ratios of incident HF for a SD increase in body mass index was elevated in women with menopausal age <45 years [1.39 (1.05-1.84)]; 45-49 years [1.33, (1.06-1.67)]; and ≥55 years [2.02, (1.41-2.89)]. The hazard ratio of incident HF for a SD increase in waist circumference was elevated only in women with menopausal age ≥55 years [2.93, (1.85-4.65)]. Conclusions As obesity worsened, the risk of developing HF became significantly greater when compared with women with lower body mass index and waist circumference, particularly among those who had experienced menopause at age ≥55 years.Note
Open access journalISSN
2047-9980PubMed ID
35416049Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1161/JAHA.121.024461
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License.
Related articles
- Long-term hormone therapy for perimenopausal and postmenopausal women.
- Authors: Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J
- Issue date: 2017 Jan 17
- Hormone therapy for preventing cardiovascular disease in post-menopausal women.
- Authors: Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B
- Issue date: 2015 Mar 10
- Infection-Related Hospitalization and Incident Heart Failure: The Atherosclerosis Risk in Communities Study.
- Authors: Molinsky RL, Shah A, Yuzefpolskaya M, Yu B, Misialek JR, Bohn B, Vock D, MacLehose R, Borlaug BA, Colombo PC, Ndumele CE, Ishigami J, Matsushita K, Lutsey PL, Demmer RT
- Issue date: 2025 Feb 4
- Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.
- Authors: Mustafa HJ, Seif K, Javinani A, Aghajani F, Orlinsky R, Alvarez MV, Ryan A, Crimmins S
- Issue date: 2022 Sep
- Association of Sarcopenic Obesity and Osteoporosis in Postmenopausal Women: Risk Factors and Protective Effects of Hormonal Therapy and Nutritional Status.
- Authors: Chucherd O, Vallibhakara O, Vallibhakara SA, Sophonsritsuk A, Chattrakulchai K, Anantaburarana M
- Issue date: 2025 Jun 26

